Antiangiogenic Nanomodulator Enhances Immune Response in Triple Negative Breast Cancer by Synergism of Photothermal Therapy and Transforming Growth Factor-β Blockade
Hao Jiang,Yilang He,Jia Zhao,Ruimin Chang,HaiLun He,Tan Li,Xingyu Zhang,Bo Shu,Wenxuan Zhang,Zhongjun Li,Huaiyu Wang,Jing Liu,Shubing Zhang,Yuetao Zhao
DOI: https://doi.org/10.2139/ssrn.4233596
2022-01-01
SSRN Electronic Journal
Abstract:Immune exclusion by transforming growth factor-β (TGF-β) predicts poor outcomes for immunotherapy of triple-negative breast cancer (TNBC). Combination of photothermal therapy (PTT) and antiangiogenesis with tumor immunotherapy is promising to argument antitumor benefit synergistically. Herein, we develop a potential immunostimulatory nanomodulator for TNBC treatment via synergism of PTT, antiangiogenesis, and priming of tumoral suppressive immune microenvironment by blocking TGF-β pathway. The nanomodulator, namely Vac@Apt@BPs, was developed by conjugation of TGF-β inhibitor Vactosertib (Vac) and nucleolin-recognizing aptamer (Apt) on the surface of black phosphorus nanoparticles (BPs). Via combination of photothermal effect and TGF-β blockade, Vac@Apt@BPs effectively inhibits the formation of tumor neovascular, and boosts robust immune response by promoting maturation of dendritic cells, suppressing regulatory T cells, and stimulating effective T cells. Together with the tumor eradication by PTT, this synergistic strategy potentially suppresses the growth of TNBC in mice.Funding Information: This work was supported by grants from the National Natural Science Foundation of China (No.32000931, 81672632, 81972312, and 82103184), the Natural Science Foundation of Hunan Province for outstanding Young Scholars (No.2021JJ20083), Natural Science Foundation of Hunan Province of China (No.2021JJ30912, 2021JJ40720 and 2021JJ30950), and the Open Sharing Fund for the Large-scale Instruments and Equipment of Central South University, Changsha, China. Declaration of Interests: The authors declare that they have no conflict of interest. Ethics Approval Statement: All the in vivo experiments were approved by the Animal Ethics Committee of the School of Life Science, Central South University (2021-2-6).